Wird geladen...
Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
SIMPLE SUMMARY: Anti-angiogenic therapies targeting the vascular endothelial growth factor (VEGF) signaling are established in the arsenal of cancer treatments. Despite the expectations, their benefits are temporary in cancer patients, partly due to the compensatory function of other angiogenic grow...
Gespeichert in:
| Veröffentlicht in: | Cancers (Basel) |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003808/ https://ncbi.nlm.nih.gov/pubmed/33804681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061422 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|